UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 487

Sortiert nach

Evaluating interior surfaces including finishing materials, ceiling, and their contribution to solar energy in residential buildings in Famagusta, North-Cyprus, Turkey

Renewable & sustainable energy reviews, 2017-08, Vol.75, p.338-353

2017

Volltextzugriff (PDF)

Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles

Biomaterials, 2012-07, Vol.33 (21), p.5414-5422

2012

Volltextzugriff (PDF)

High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)

Leukemia, 2015-09, Vol.29 (9), p.1928-1938

2015

Volltextzugriff (PDF)

Is isolation of comprehensive human plasma peptidomes an achievable quest?

Journal of proteomics, 2015-09, Vol.127 (Pt B), p.300-309

2015

Volltextzugriff (PDF)

Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B

Journal of experimental & clinical cancer research, 2019-07, Vol.38 (1), p.332-332, Article 332

2019

Volltextzugriff (PDF)

Preclinical modeling of myelodysplastic syndromes

Leukemia, 2017-12, Vol.31 (12), p.2702-2708

2017

Volltextzugriff (PDF)

The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment

Journal of investigative dermatology, 2013-04, Vol.133 (4), p.1052-1062

2013

Volltextzugriff (PDF)

Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET

Journal of Nuclear Medicine, 2008-04, Vol.49 (4), p.667-673

2008

Volltextzugriff (PDF)

Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies

Haematologica (Roma), 2013-09, Vol.98 (9), p.1397-1406

2013

Volltextzugriff (PDF)

Targeting of Tumor Neovasculature with GrB/VEGF121, a Novel Cytotoxic Fusion Protein

Biomedicines, 2017-07, Vol.5 (3), p.42

2017

Volltextzugriff (PDF)

Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF121/rGel fusion toxin

Journal of controlled release, 2014-04, Vol.180, p.1-9

2014

Volltextzugriff (PDF)

PET of Vascular Endothelial Growth Factor Receptor Expression

The Journal of nuclear medicine (1978), 2006-12, Vol.47 (12), p.2048-2056

2006

Volltextzugriff (PDF)

Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy

Journal of controlled release, 2018-10, Vol.288, p.161-172

2018

Volltextzugriff (PDF)

The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

Leukemia, 2006-07, Vol.20 (7), p.1319-1321

2006

Volltextzugriff (PDF)

Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2

BMC cancer, 2011-08, Vol.11 (1), p.358-358, Article 358

2011

Volltextzugriff (PDF)

The JAK2 V617F mutation is rare in RARS but common in RARS-T

Leukemia, 2006-11, Vol.20 (11), p.2060-2061

2006

Volltextzugriff (PDF)

Multiplexed PET Probes for Imaging Breast Cancer Early Response to VEGF121/rGel Treatment

Molecular pharmaceutics, 2011-04, Vol.8 (2), p.621-628

2011

Volltextzugriff (PDF)

Improving Porosity of Activated Carbon Nanotubes via Alkali Agents for the Enhancement of Adsorptive Desulfurization Process

Materials science forum, 2020-07, Vol.1002, p.423-434

2020

Volltextzugriff (PDF)

Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF(121)/rGel fusion toxin

Journal of controlled release, 2014-04, Vol.180, p.1

2014

Volltextzugriff (PDF)

Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel

Cancer research (Chicago, Ill.), 2006-11, Vol.66 (22), p.10919-10928

2006

Volltextzugriff (PDF)

Noncovalent Functionalization of Carbon Nanovectors with an Antibody Enables Targeted Drug Delivery

ACS nano, 2011-08, Vol.5 (8), p.6643-6650

2011

Volltextzugriff (PDF)

Sensitive Angiogenesis Imaging of Orthotopic Bladder Tumors in Mice Using a Selective Magnetic Resonance Imaging Contrast Agent Containing VEGF121/rGel

Investigative radiology, 2011-07, Vol.46 (7), p.441-449

2011

Volltextzugriff (PDF)

Characterization and Mechanistic Studies of a Novel Melanoma-Targeting Construct Containing IκBa for Specific Inhibition of Nuclear Factor-κB Activity

Neoplasia (New York, N.Y.), 2010-10, Vol.12 (10), p.766,IN1-777,IN2

2010

Volltextzugriff (PDF)

Multimodality Molecular Imaging of Glioblastoma Growth Inhibition with Vasculature-Targeting Fusion Toxin VEGF121/rGel

The Journal of nuclear medicine (1978), 2007-03, Vol.48 (3), p.445-454

2007

Volltextzugriff (PDF)

Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu

Molecular cancer therapeutics, 2013-06, Vol.12 (6), p.979-991

2013

Volltextzugriff (PDF)

1 – 25 von 487

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(429)
Mit Volltextzugriff
(438)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Evaluating interior surfaces including finishing materials, ceiling, and their contribution to solar energy in residential buildings in Famagusta, North-Cyprus, Turkey

Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles

High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)

Is isolation of comprehensive human plasma peptidomes an achievable quest?

Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B

Preclinical modeling of myelodysplastic syndromes

The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment

Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET

Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies

Targeting of Tumor Neovasculature with GrB/VEGF121, a Novel Cytotoxic Fusion Protein

Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF121/rGel fusion toxin

PET of Vascular Endothelial Growth Factor Receptor Expression

Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy

The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2

The JAK2 V617F mutation is rare in RARS but common in RARS-T

Multiplexed PET Probes for Imaging Breast Cancer Early Response to VEGF121/rGel Treatment

Improving Porosity of Activated Carbon Nanotubes via Alkali Agents for the Enhancement of Adsorptive Desulfurization Process

Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF(121)/rGel fusion toxin

Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel

Noncovalent Functionalization of Carbon Nanovectors with an Antibody Enables Targeted Drug Delivery

Sensitive Angiogenesis Imaging of Orthotopic Bladder Tumors in Mice Using a Selective Magnetic Resonance Imaging Contrast Agent Containing VEGF121/rGel

Characterization and Mechanistic Studies of a Novel Melanoma-Targeting Construct Containing IκBa for Specific Inhibition of Nuclear Factor-κB Activity

Multimodality Molecular Imaging of Glioblastoma Growth Inhibition with Vasculature-Targeting Fusion Toxin VEGF121/rGel

Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu

Suchergebnisse filtern